Expression of membrane type 1-matrix metalloproteinase in laryngeal carcinoma

B Du1, P Wang, X Guo

  • 1Norman Bethune University of Medical Sciences, Department of ENT & HN, First Clinical Hospital, Chang-Chun, Ji Lin, 130021, P.R. China. dubo2000@hotmail.com

Insights

High expression of membrane type 1-matrix metalloproteinase (MT1-MMP) in laryngeal carcinoma correlates with advanced disease and poorer survival. This suggests MT1-MMP may drive tumor invasion and metastasis.

Area of Science:

  • Oncology
  • Molecular Biology
  • Biochemistry

Background:

  • Membrane type 1-matrix metalloproteinase (MT1-MMP) is a key enzyme involved in extracellular matrix degradation.
  • MT1-MMP plays a role in cell surface progelatinase A (MMP-2) activation.
  • Understanding MT1-MMP's role in cancer is crucial for prognosis.

Purpose of the Study:

  • To analyze MT1-MMP mRNA expression in laryngeal carcinoma.
  • To investigate the correlation between MT1-MMP expression and clinicopathological features.
  • To determine the relationship between MT1-MMP expression and patient survival.

Main Methods:

  • Reverse transcription polymerase chain reaction (RT-PCR) was used to quantify MT1-MMP mRNA levels.
  • Expression analysis was performed on 45 laryngeal carcinoma tissue samples.
  • Survival analysis was conducted on 18 of these cases.

Main Results:

  • MT1-MMP mRNA expression was significantly higher in tumor tissues compared to normal tissues.
  • Expression levels increased with clinical stage (Stage III > Stage II).
  • Higher MT1-MMP expression was observed in patients with lymph node metastasis.
  • Elevated MT1-MMP expression was associated with significantly poorer 5-year survival.

Conclusions:

  • High MT1-MMP expression is linked to increased invasion and metastasis in laryngeal carcinoma.
  • MT1-MMP serves as a potential biomarker for poor prognosis in laryngeal cancer.
  • Targeting MT1-MMP could be a therapeutic strategy for laryngeal carcinoma.

Related Concept Videos

lncRNA - Long Non-coding RNAs02:39

lncRNA - Long Non-coding RNAs

In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA (lncRNA)...
Metastasis02:30

Metastasis

Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Role of Matrix Metalloproteases in Degradation of ECM01:23

Role of Matrix Metalloproteases in Degradation of ECM

Matrix metalloproteases (MMPs) are enzymes involved in the hydrolysis of proteins and glycoproteins of the extracellular matrix. MMPs are essential for the migration and proliferation of cells through the dense matrix network, throughout embryonic development, and throughout morphogenesis. The first MMP activity discovered was a collagenase in a tadpole's tail undergoing metamorphosis. The active collagen deposition and modifications lead to the morphogenesis of tadpoles into the adult body.
A...